Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by cavinsinon Mar 13, 2017 5:48pm
275 Views
Post# 25973646

RE:RE:RE:Movantik...

RE:RE:RE:Movantik...Big risk, big reward, PLX is, not GUD.
On Thursday morning they will release 2016 financial results and Corporate update, I am riding it through. Company has website where you can find out whats in pipeline.
I dont think there is any chance this will go to zero, and I believe the upside here is huge.
Dont understand how you thinking doubling down through GUD. PLX results will have no effect on GUD S/P, on Thursday or beyond.
I know how to double down with blackjack, after you receive two cards you can double your bet but you are only allowed to take one additinal card.
If you trying to protect your investment from today, against price drop on Thursday, you may want to look into buying PUT's
I just checked $ 1.00 PUT is available for $0.10c
$ 2.00 PUT is available for $ 0.85c
Bullboard Posts